Skip to main content

Advertisement

SpringerLink
Log in

Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

To study the hypothesis of detecting bladder inflammation associated with overactive bladder (OAB) through altered urine levels of cytokines, chemokines, and growth factors.

Methods

Midstream urine specimens were collected from a prospective study done on eight asymptomatic control subjects and 17 idiopathic OAB patients. The urine was analyzed by a multiplex panel screen for 12 chemokines, cytokines, growth factors, and soluble receptors using Luminex™ xMAP® technology. Protein concentration values were normalized to the levels of creatinine.

Results

This analysis revealed a significant elevation of seven key proteins in the urine of OAB patients relative to controls (*P < 0.05). A greater than tenfold elevation was measured in OAB, relative to controls, in the levels of monocyte chemotactic protein-1 (MCP-1), soluble fraction of the CD40 ligand (sCD40L) in urine was obtained from OAB patients relative to controls. At least five fold elevations were detected in the levels of macrophage inflammatory protein (MIP-1β), IL-12p70/p40, IL-5, epidermal growth factor (EGF), and growth-related oncogene GRO-α compared to controls. Significant threefold elevation was also noticed in the urine levels of sIL-2Rα, and IL-10 in the OAB group. The levels of the remaining proteins tested were not statistically significantly different from control values.

Conclusions

The presence of elevated levels in urine of inflammatory biomarkers involved in inflammation and tissue repair suggests a role for inflammation in OAB, and may help in diagnosis and treatment of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tyagi S, Thomas CA, Hayashi Y, Chancellor MB (2006) The overactive bladder: epidemiology and morbidity. Urol Clin North Am 33:433–438, vii

    Google Scholar 

  2. Steers W (2000) Pathogenesis of the overactive bladder and its attendant risk factors. BJU Int 85(Suppl 3):69 (discussion 70–71)

    PubMed  Google Scholar 

  3. Segerer S, Nelson PJ (2005) Chemokines in renal diseases. ScientificWorldJournal 5:835–844

    Article  CAS  PubMed  Google Scholar 

  4. Tesch GH (2008) MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 294:F697–F701

    Article  CAS  PubMed  Google Scholar 

  5. Ferri GM, Gigante A, Ferri F et al (2007) Urine chemokines: biomarkers of human lupus nephritis? Eur Rev Med Pharmacol Sci 11:171–178

    CAS  PubMed  Google Scholar 

  6. Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R (2007) Urinary biomarkers in septic acute kidney injury. Intensive Care Med 33:1285–1296

    Article  CAS  PubMed  Google Scholar 

  7. Li Y, Tucci M, Narain S et al (2006) Urinary biomarkers in lupus nephritis. Autoimmun Rev 5:383–388

    Article  CAS  PubMed  Google Scholar 

  8. Comperat E, Reitz A, Delcourt A, Capron F, Denys P, Chartier-Kastler E (2006) Histologic features in the urinary bladder wall affected from neurogenic overactivity—a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 50:1058–1064

    Article  CAS  PubMed  Google Scholar 

  9. Apostolidis A, Jacques TS, Freeman A et al (2008) Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Eur Urol 53:1245–1253

    Article  CAS  PubMed  Google Scholar 

  10. Nathan C (2002) Points of control in inflammation. Nature 420:846–852

    Article  CAS  PubMed  Google Scholar 

  11. Innerfield I, Gimble FS, Blincoe E III (1963) Peptidase activity in rat urine following orally given proteases. Life Sci 9:671–675

    Article  CAS  PubMed  Google Scholar 

  12. Abrams P (2005) Urgency: the key to defining the overactive bladder. BJU Int 96(Suppl 1):1–3

    Article  PubMed  Google Scholar 

  13. Nixon A, Colman S, Sabounjian L et al (2005) A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 174:604–607

    Article  PubMed  Google Scholar 

  14. Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345–350

    Article  CAS  PubMed  Google Scholar 

  15. Loran OB, Pisarev SA, Kleimenova NV, Sukhorukov VS (2007) Allergic inflammation as one of the factors of pathogenesis of overactive urinary bladder. Urologiia 2:37–41

    Google Scholar 

  16. Bouchelouche K, Alvarez S, Andersen L, Nordling J, Horn T, Bouchelouche P (2004) Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells. J Urol 171:462–466

    Article  CAS  PubMed  Google Scholar 

  17. Bouchelouche K, Alvarez S, Horn T, Nordling J, Bouchelouche P (2006) Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha. Urology 67:214–219

    Article  PubMed  Google Scholar 

  18. Moser B, Schumacher C, von Tscharner V, Clark-Lewis I, Baggiolini M (1991) Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem 266:10666–10671

    CAS  PubMed  Google Scholar 

  19. Smaldone M, Vodovotz Y, Tyagi V et al (2009) Multiplex analysis of urinary cytokine levels in a rat model of cyclophosphamide-induced cystitis. Urology 73(2):421–426

    Google Scholar 

  20. Khadra A, Fletcher P, Luzzi G, Shattock R, Hay P (2006) Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis. BJU Int 97:1043–1046

    Article  CAS  PubMed  Google Scholar 

  21. Torrence AE, Brabb T, Viney JL et al (2008) Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease. Inflamm Bowel Dis 14(4):480–490

    Google Scholar 

  22. Otto G, Burdick M, Strieter R, Godaly G (2005) Chemokine response to febrile urinary tract infection. Kidney Int 68:62–70

    Article  CAS  PubMed  Google Scholar 

  23. Ferroni P, Guadagni F (2008) Soluble CD40L and its role in essential hypertension: diagnostic and therapeutic implications. Cardiovasc Hematol Disord Drug Targets 8:194–202

    Article  CAS  PubMed  Google Scholar 

  24. Bastian D, Tamburstuen MV, Lyngstadaas SP, Reikeras O (2008) Systemic and local cytokine kinetics after total hip replacement surgery. Eur Surg Res 41:334–340

    CAS  PubMed  Google Scholar 

  25. Bhangoo S, Ren D, Miller RJ et al (2007) Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain 3:38

    Article  PubMed  Google Scholar 

  26. Rossato M, Cencig S, Gasperini S, Cassatella MA, Bazzoni F (2007) IL-10 modulates cytokine gene transcription by protein synthesis-independent and dependent mechanisms in lipopolysaccharide-treated neutrophils. Eur J Immunol 37:3176–3189

    Article  CAS  PubMed  Google Scholar 

  27. White FA, Wilson NM (2008) Chemokines as pain mediators and modulators. Curr Opin Anaesthesiol 21:580–585

    Article  PubMed  Google Scholar 

  28. Kimball ES, Prouty SP, Pavlick KP, Wallace NH, Schneider CR, Hornby PJ (2007) Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis. Neurogastroenterol Motil 19:390–400

    Article  CAS  PubMed  Google Scholar 

  29. Qin X, Wan Y, Wang X (2005) CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons. J Neurosci Res 82:51–62

    Article  CAS  PubMed  Google Scholar 

  30. Xie WR, Deng H, Li H, Bowen TL, Strong JA, Zhang JM (2006) Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia. Neuroscience 142:809–822

    Article  CAS  PubMed  Google Scholar 

  31. Good DM, Thongboonkerd V, Novak J et al (2007) Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 6(12):4549–4555

    Google Scholar 

  32. Candela JV, Park E, Gerspach JM et al (1998) Evaluation of urinary IL-1alpha and IL-1beta in gravid females and patients with bacterial cystitis and microscopic hematuria. Urol Res 26:175–180

    Article  CAS  PubMed  Google Scholar 

  33. Goto T, Morioka J, Inamura H et al (2007) Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity. Allergol Int 56:433–438

    Article  CAS  PubMed  Google Scholar 

  34. Zimmerli LU, Schiffer E, Zurbig P et al (2008) Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 7(2):290–298

    Google Scholar 

  35. Malayappan B, Garrett TJ, Segal M, Leeuwenburgh C (2007) Urinary analysis of 8-oxoguanine, 8-oxoguanosine, fapy-guanine and 8-oxo-2′-deoxyguanosine by high-performance liquid chromatography-electrospray tandem mass spectrometry as a measure of oxidative stress. J Chromatogr A 1167:54–62

    Article  CAS  PubMed  Google Scholar 

  36. Boeniger MF, Lowry LK, Rosenberg J (1993) Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 54:615–627

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Drs. Bruce Jacob and Wendy Leng for helping with urine collection. This study was supported in part by a research grant from Pfizer and National Institute on Disability Rehabilitation Research grant H133E070024.

Author information

Authors and Affiliations

  1. Department of Urology, William Beaumont Hospital, Royal Oak, MI, 48073, USA

    Pradeep Tyagi, Kenneth Peters & Michael Chancellor

  2. Department of Urology, University of Pittsburgh, Pittsburgh, PA, 15213, USA

    Naoki Yoshimura

  3. Department of Surgery, University of Pittsburgh, Pittsburgh, PA, 15213, USA

    Derek Barclay, Ruben Zamora & Yoram Vodovotz

  4. Center for Inflammation and Regenerative Modeling, University of Pittsburgh, Pittsburgh, PA, 15219, USA

    Yoram Vodovotz

Authors
  1. Pradeep Tyagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Derek Barclay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ruben Zamora
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naoki Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenneth Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoram Vodovotz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael Chancellor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Chancellor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tyagi, P., Barclay, D., Zamora, R. et al. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42, 629–635 (2010). https://doi.org/10.1007/s11255-009-9647-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-009-9647-5

Keywords

Search

Navigation